Delivery Order SPE2DB20D3101-SPE2DB24FRNR0
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,967.79, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a specialized pharmaceutical product. The contract has an ultimate completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,541.10, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of November 7, 2024. This contract award is not designated as a set-aside. AmerisourceBergen holds a...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,589.44 firm fixed-price contract is for the supply of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The contract has an ultimate completion date of July 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,990.05, is for the delivery of Advair HFA 230-21 MCG inhalers. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is the prime contractor and there are no noted subcontractors. This contract is not set aside and is part of a larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The $7,801.08 contract has a completion date of May 23, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The contract has a firm fixed price of $3,975.72 and an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,989.93, is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 27, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, with a potential value of $1,987.86 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 115-21 MCG Inhaler in 12 gram quantities, with a ceiling value of $3,856.08 and a performance period through June 3, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication, with a ceiling value of $1,830.06 and a period of performance through June 25, 2025. The contract is not set aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRNR0Delivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,354.52, is for the delivery of Advair HFA 230-21 MCG Inhaler 8GM. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 6/25/24 |